#VisualAbstract: Talazoparib plus enzalutamide improves progression-free survival in metastatic prostate cancer
Click to read the study in The Lancet ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: talazoparib
Talazoparib plus enzalutamide improves progression-free survival in metastatic prostate cancer
1. Progression-free survival was significantly higher in the talazoparib plus enzalutamide group compared to enzalutamide alone. 2. There were no ...